Alseres Pharmaceuticals Alternatives & Competitors

12 companies similar to Alseres Pharmaceuticals

CNS Therapeutics

Delivering advanced neurological and pain treatments with precision and expertise

4 Venture round $10.05M

Saint Paul, United States

Biotechnology Health Care

CNS Pharmaceuticals, Inc.

Pre-Clinical Stage Biotech Company Focused on Developing Novel Treatments for Brain Tumors

9 Post-IPO Equity $22.87M

Houston, United States

Biotechnology Health and Wellness +2

AGY Therapeutics

Pioneering breakthrough treatments for central nervous system diseases through innovative...

Series C $22.00M

Biopharma Biotechnology +1

IRLAB Therapeutics AB

A clinical-stage biopharma discovering and developing novel treatments for the most troubl...

37 Grant $158.67M

Sweden

Health Care Health and Wellness

Track all Alseres Pharmaceuticals competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Neurologix

Innovative therapies for brain and neurological disorders with a focus on gene therapy tre...

Venture round $7.00M

Biotechnology Health and Wellness

ADARx Pharmaceuticals Inc.

Our vision is to provide effective and safe RNA therapeutics to patients who suffer from i...

94 Series C $327.00M

San Diego, United States

Biotechnology Health Care +1

Algiax Pharmaceuticals

Disarming chronic neuropathic pain

5 $4.30M

Erkrath, Germany

Biotechnology Health Care +1

ConSynance Therapeutics, Inc.

Pioneering groundbreaking treatments for NASH, Prader-Willi Syndrome, and IBS with a stron...

Rensselaer, United States

Biotechnology Health and Wellness

Addex Therapeutics

Allosteric modulators for Human Health

19 Post-IPO Equity $139.84M

Plan-les-ouates, Switzerl...

Biotechnology Health Care +1

LISCure Biosciences Inc.

Live Biotherapeutics Immunotherapeutic Drugs

6 Series B $17.50B

Korea South

Biotechnology Health Care

Trimel Pharmaceuticals

Pioneering innovative solutions for male hypogonadism, female sexual dysfunction, and resp...

Post-IPO Equity $72.45M

Biotechnology Health Care

Newron Pharmaceuticals SpA

The Specialist in CNS Drug Development

23 Post-IPO Equity $129.36M

Bresso, Italy

Biopharma Biotechnology +1

Frequently Asked Questions

Companies similar to Alseres Pharmaceuticals include CNS Therapeutics, CNS Pharmaceuticals, Inc., AGY Therapeutics, IRLAB Therapeutics AB, Neurologix. They work in Biotechnology and Health Care.

Bounce Watch lists 12 companies that share Alseres Pharmaceuticals's industries and are closest to it in business tags, services, target customers, business model and size.

Alseres Pharmaceuticals is a biotech company, established in 1972, that is dedicated to developing diagnostic and therapeutic solutions for central nervous system disorders. The company's flagship product, Altropane®, is a pioneering molecular imaging agent designed for diagnosing Parkinson's disease and dementia. Curr...

Don't just read about them. Follow them.

BounceWatch watches Alseres Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Alseres Pharmaceuticals Profile CNS Therapeutics Alternatives CNS Pharmaceuticals, Inc. Alternatives AGY Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Alseres Pharmaceuticals on 21 Jun 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.